Kishi, Takuya <br/><br/>
Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure.  [electronic resource] 

 -  American journal of hypertension  Feb 2014 
 - 260-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7225 
<br/><br/><label>Standard No.: </label>10.1093/ajh/hpt188  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Animals<br/>Benzimidazoles--therapeutic use<br/>Benzoates--therapeutic use<br/>Biphenyl Compounds--therapeutic use<br/>Heart Failure--drug therapy<br/>Hypertension--drug therapy<br/>Hypertrophy, Left Ventricular--drug therapy<br/>Medulla Oblongata--drug effects<br/>Norepinephrine--urine<br/>Rats<br/>Rats, Inbred SHR<br/>Reactive Oxygen Species--metabolism<br/>Telmisartan<br/>Tetrazoles--therapeutic use<br/>Ventricular Function, Left--drug effects